Studies on the influence of duodenal and small intestinal microbiota and bile acids on the pathogenesis of liver diseases

Studies on the influence of duodenal and small intestinal microbiota and bile acids on the pathogenesis of liver diseases - Studies on the influence of duodenal and small intestinal microbiota and bile acids on the pathogenesis of liver diseases

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000047827

Enrollment

150

Registered

2022-06-01

Start date

2022-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-alcoholic fatty liver disease(NAFLD) metabolic associated fatty liver disease(MAFLD)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Liver disease patients (priority to non-alcoholic fatty liver disease and metabolic associated fatty liver disease) . Patients with non-liver disease scheduled for endoscopy.

Exclusion criteria

Exclusion criteria: Patients who do not agree with the study. Patients who cannot understand the explanation of the study. Patients who cannot underdo endoscopy due to their general condition.

Design outcomes

Primary

Measure	Time frame
Identification of diversity and characteristic species of small intestinal microbiota in non-alcoholic fatty liver disease/metabolic associated fatty liver disease	—

Secondary

Measure	Time frame
Identification of metabolic dysfunctions of the small intestinal microbiota in non-alcoholic fatty liver disease/metabolic associated fatty liver disease	—

Countries

Japan

Contacts

Public ContactKazuki Niida

Ehime University Graduate School of Medicine Department of Gastroenterology and Metabology

3naika@m.ehime-u.ac.jp089-960-5308

Outcome results